Clinical trials sponsored by The First Affiliated Hospital of Xiamen University

Phase breakdown

Conditions studied

Recruiting trials led by The First Affiliated Hospital of Xiamen University

• 68Ga-XACP3 PET/CT in Prostate Cancer
  NCT07242014 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• A Prospective Nurse Cohort Study in Xiamen, China
  NCT03799653 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
  NCT06387056 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
  NCT03087032 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)
  NCT05841615 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
  NCT06929936 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
  NCT06992739 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is The First Affiliated Hospital of Xiamen University recruiting for?

The First Affiliated Hospital of Xiamen University is the lead sponsor of 7 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.